Abstract:Objective To investigate the role of MicroRNA-27a (miR-27a) in the anti-apoptotic effects of liraglutide (LR) in cardiomyocytes. Methods The H9c2 rat cardiomyocytes were cultured in different environment and divided into low glucose group, high glucose group, miR-27a over-expression group, miR-27a inhibited group, miR-27a negative over-expression group, miR-27a negative inhibited group, liposome 2000 group, hypertonic solution group, LR intervention group, LR intervention and miR-27a over-expression group, LR intervention and miR-27a negative over-expression group. The expression of miR-27a in cardiomyocytes, which were cultured in low glucose solution, high glucose solution and interferenced by LR, was detected by fluorescence-based real-time quantitative polymerase chain reaction (PCR). The apoptosis of cardiomyocytes was detected by terminal-deoxynucleoitidyl transferase mediated nick end labeling (TUNEL) and then the cell apoptosis index (AI) was computed and compared among the groups. The expression of apoptosis-related protein B-cell lymphoma/leukemia-2 (Bcl-2), Bcl-2 associated X protein (Bax), cysteine-containing aspartate-specific proteases-3 (caspase-3), cellular inhibitors of apoptosis-1 (cIAP-1), anti-apoptotic protease activating factor-1 (Apaf-1) was detected by Western blotting method. Data were analyzed with one-way analysis of variance test or t test. Results The expression of miR-27a in high glucose group was higher than that in low glucose group(35.8±4.9 vs 1.0±0.0, t=12.199, P<0.05). Compared with the high glucose group, the AI of cardiomyocytes increased significantly in miR-27a over-expression group (78.5 ± 6.6 vs 22.9 ± 1.7, least-significant difference (LSD), P<0.05), and the protein expression of Bcl-2 and cIAP-1 decreased (LSD, both P<0.05), the protein expression of Bax, caspase-3 and Apaf-1 increased(LSD, all P<0.05). Compared with the high glucose group, the AI of cardiomyocytes decreased significantly in miR-27a inhibition group (2.6 ± 0.4 vs 22.9 ± 1.7, LSD, P<0.05), and the protein expression level of Bcl-2 and cIAP-1 increased (LSD, both P<0.05), the protein expression level of Bax, caspase-3 and Apaf-1 significantly decreased(LSD, all P<0.05). Compared with the high glucose group, the expression level of miR-27a decreased significantly in LR intervention group (7.9 ± 0.2 vs 35.8 ± 4.9, t=-9.785, P<0.05), and the AI of cardiomyocytes decreased remarkably (4.9±0.1 vs 22.9±1.7, LSD, P<0.05). The AI of cardiomyocytes increased in LR intervention and miR-27a over-expression group when compared with that in LR intervention group (61.3 ± 5.1 vs 4.9 ± 0.1, LSD, P<0.05). Conclusion LR may ameliorate the apoptosis of cardiomyocytes in the condition of high glucose by inhibiting the expression of miR-27a in H9c2 rat cardiomyocytes.

Upregulation of Mirna-23A-3p Rescues High Glucose-Induced Cell Apoptosis and Proliferation Inhibition in Cardiomyocytes

MiR-32-5p Influences High Glucose-Induced Cardiac Fibroblast Proliferation and Phenotypic Alteration by Inhibiting DUSP1

Retracted: MicroRNA‐132 Protects H9c2 Cells Against Oxygen and Glucose Deprivation‐evoked Injury by Targeting FOXO3A

Upregulation of Mir-21-5p Rescues the Inhibition of Cardiomyocyte Proliferation Induced by High Glucose Through Negative Regulation of Rhob.

MicroRNA-34a Regulates High Glucose-Induced Apoptosis in H9c2 Cardiomyocytes

[Mir-494-3p Reduces Insulin Sensitivity in Diabetic Cardiomyocytes by Down-Regulation of Insulin Receptor Substrate 1].

Glucose induces apoptosis of cardiomyocytes via microRNA-1 and IGF-1.

Dihydromyricetin Prevents Diabetic Cardiomyopathy via miR-34a Suppression by Activating Autophagy

Abstract 5441: the Roles for MicroRNA-221 and IGF-1 Signaling in Regulation of High Glucose-Induced Endothelial Dysfunction and Apoptosis

Effects of high glucose on apoptosis and miR-34a expression of H9c2 cells

miR-23b-3p induces the cellular metabolic memory of high glucose in diabetic retinopathy through a SIRT1-dependent signalling pathway

MiRNA-144-3p Inhibits High Glucose Induced Cell Proliferation Through Suppressing FGF16.

MicroRNA-494 regulates high glucose-induced cardiomyocyte apoptosis and autophagy by PI3K/AKT/mTOR signalling pathway

Effects of Mir-155 on High Glucose Induced-Cardiac Developmental Defects of Zebrafish Embryos

Glucose Impairs Angiogenesis and Promotes Ventricular Remodelling Following Myocardial Infarction Via Upregulation of Microrna-17

Microrna-182-5p Protects H9c2 Cardiomyocytes From Hypoxia-Induced Apoptosis By Down-Regulation Of Pten

Role of Mir-19B in Protecting Cardiomyocytes from Apoptosis by Activating Akt Signaling

Overexpression of Mir‑17‑5p Protects Against High Glucose‑induced Endothelial Cell Injury by Targeting E2F1‑mediated Suppression of Autophagy and Promotion of Apoptosis

Role of Microrna-27A in the Anti-Apoptotic Effects of Liraglutide in Cardiomyocytes

[Microrna-182 Modulates High Glucose-Induced Cardiomyocyte Hypertrophy Via Targeting Rac1].

MicroRNA-9-5p Promotes Angiogenesis but Inhibits Apoptosis and Inflammation of High Glucose-Induced Injury in Human Umbilical Vascular Endothelial Cells by Targeting CXCR4